Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Feb 17 2023

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-17-2023-9

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 17, 2023, titled "Glenmark Pharmaceuticals receives 2nd ANDA tentative approval for Saxagliptin Tablets, 2.5 mg and 5 mg".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases